31.08.2015
- The US Food and Drug Administration has released a proposal for naming biosimilars – lower-cost biotech drugs – almost simultaneously with the market launch of the first such...
16.03.2015
- The US Food & Drug Administration has approved the country's first biosimilar product, a move observers say will open the door for lower cost, generic-like biological drugs. The...
11.05.2013
- The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...
07.05.2013
- Slower growth in the pace of U.S. healthcare spending reflects a fundamental change in the use of medical services that could save the country nearly $800 billion in the next...
29.03.2013
- The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...
14.02.2013
- President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially lose...
06.10.2012
- The Obama administration's reluctance to push for 12 years of data protection on "biologic" medicines in free-trade talks is a growing concern for U.S. drug manufacturers who...
02.08.2012
- Laboratory Corp of America Holdings said it has no knowledge of any plans for a leveraged buyout of the company after a report that a private equity consortium was targeting the...
